IRF-1 may suppress tumor proliferation by inhibiting the cell cycle, reducing susceptibility to transformation by oncogenes or inducing apoptosis, development of natural killer (NK) cells and differentiation of Th1 and CD8+ T cells. This evidence concerns the gene IRF1 and neoplasm.